INmune Bio Inc. Common stock
$2.33
$0.15 (+6.88%)
$2.21Day Range$2.40
Key Statistics
Market Cap
$60.50M
Shares Outstanding
27.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 4, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$2.22
Day High
$2.40
Day Low
$2.21
Volume
677.6K
VWAP
$2.32
Prev Close
$2.18
Transactions
--
Acc. Volume
--
About INmune Bio Inc. Common stock
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283621 employees225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432(858) 964-3720IPO Feb 4, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001711754
- Composite FIGI
- BBG00LW94L98
- Share Class FIGI
- BBG00LW94M14
- Ticker Root
- INMB
- SIC Code
- 2836
About INmune Bio Inc. Common stock (INMB) Stock
INmune Bio Inc. Common stock (INMB) closed the 2026-09-18 session at $2.33, up 6.88% versus the previous close (+0.15). The stock opened at $2.22 and traded between $2.21 and $2.40 during that session. Session trading volume was 678K shares. The volume-weighted average price (VWAP) is $2.32.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
INmune Bio Inc. Common stock has a market capitalization of $60.5 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. INMB is listed on the XNAS exchange. The company employs approximately 21 people. INmune Bio Inc. Common stock is headquartered in BOCA RATON, FL. The recorded listing date is 2019-02-04.
On this page you can find market INMB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.